`Case 1:23-cv-00278-MN Document 54-5 Filed 02/09/24 Page 1 of 17 PagelD #: 1055
`
`
`
`
`
`EXHIBIT E
`EXHIBIT E
`
`
`
`
`
`Case 1:23-cv-00278-MN Document 54-5 Filed 02/09/24 Page 2 of 17 PageID #: 1056
`Case 1:23-cv-00278-MN Document 54-5 Filed 02/09/24 Page 2 of 17 PagelD #: 1056
`
`UNITED STATES
`PATENT AND TRADEMARK OFFICE
`
`
`
`
`
`Case 1:23-cv-00278-MN Document 54-5 Filed 02/09/24 Page 3 of 17 PageID #: 1057
`
`PTAB Trial Statistics
`FY23 End of Year Outcome Roundup
`IPR, PGR
`Patent Trial and Appeal Board
`Fiscal Year 2023
`
`
`
`Case 1:23-cv-00278-MN Document 54-5 Filed 02/09/24 Page 4 of 17 PageID #: 1058
`
`Petitions filed by trial type
`(FY23: Oct. 1, 2022 to Sept. 30, 2023)
`
`IPR
`1,209
`98%
`
`1,239
`Total
`
`PGR
`30
`2%
`
`Trial types include Inter Partes Review (IPR) and Post Grant Review (PGR).
`
`3
`
`
`
`Case 1:23-cv-00278-MN Document 54-5 Filed 02/09/24 Page 5 of 17 PageID #: 1059
`
`Petitions filed by technology
`(FY23: Oct. 1, 2022 to Sept. 30, 2023)
`
`Mechanical &
`Business Method
`248
`20%
`
`Chemical
`34
`3%
`Bio/Pharma
`91
`7%
`
`Design
`5
`0%
`
`1,239
`Total
`
`Electrical/Computer
`861
`69%
`
`4
`
`
`
`Case 1:23-cv-00278-MN Document 54-5 Filed 02/09/24 Page 6 of 17 PageID #: 1060
`
`Petitions filed by month
`(September2023 and Prior 12 Months: Sept. 1, 2022 to Sept. 30, 2023)
`IPR
`(1,209 IPRs in FY23)
`
`151
`
`99
`
`103
`
`112
`
`110
`
`103
`
`108
`
`127
`
`77
`
`69
`
`PGR
`3
`
`0
`Feb Mar
`
`3
`
`1
`Apr May
`
`1
`Jun
`
`2
`
`Sep
`
`1
`Oct
`
`1
`Nov
`
`2
`
`4
`
`Dec
`
`Jan
`
`87
`
`91
`
`71
`
`(30 PGRs in FY23)
`7
`4
`
`3
`
`Jul
`
`Aug
`
`Sep
`
`5
`
`
`
`Case 1:23-cv-00278-MN Document 54-5 Filed 02/09/24 Page 7 of 17 PageID #: 1061
`
`Institution rates by petition
`(FY19 to FY23: Oct. 1, 2018 to Sept. 30, 2023)
`
`by Petition
`63%
`
`859
`
`510
`
`56%
`648
`
`512
`
`Instituted
`Denied
`
`58%
`702
`
`504
`
`66%
`
`67%
`
`769
`
`397
`
`752
`
`375
`
`FY19
`
`FY20
`
`FY21
`
`FY22
`
`FY23
`
`6
`
`
`
`Institution rates by patent
`(FY19 to FY23: Oct. 1, 2018 to Sept. 30, 2023)
`by Patent
`70%
`
`Instituted
`Denied
`
`71%
`
`69%
`
`66%
`
`Case 1:23-cv-00278-MN Document 54-5 Filed 02/09/24 Page 8 of 17 PageID #: 1062
`
`667
`
`290
`
`64%
`
`567
`
`320
`
`645
`
`338
`
`661
`
`648
`
`296
`
`259
`
`FY19
`
`FY20
`
`FY21
`
`FY22
`
`FY23
`
`7
`
`
`
`Case 1:23-cv-00278-MN Document 54-5 Filed 02/09/24 Page 9 of 17 PageID #: 1063
`
`Institution rates by technology
`(FY23: Oct. 1, 2022 to Sept. 30, 2023)
`Bio/Pharma
`
`52% (43 of 82)
`
`Chemical
`
`Design
`
`Electrical/Computer
`
`49% (23 of 47)
`
`50% (4 of 8)
`
`70% (492 of 701)
`
`Mechanical &
`66% (190 of 289)
`Business Method
`Institution rate for each technology is calculated by dividing petitions instituted by
`decisions on institution (i.e., petitions instituted plus petitions denied). The outcomes
`of decisions on institution responsive to requests for rehearing are excluded.
`
`8
`
`
`
`Case 1:23-cv-00278-MN Document 54-5 Filed 02/09/24 Page 10 of 17 PageID #: 1064
`
`Settlements
`(FY19 to FY23: Oct. 1, 2018 to Sept. 30, 2023)
`Settlement Rate
`32%
`31%
`
`Settlements
`Post-
`Institution
`
`502
`
`243
`
`Pre-
`Institution 259
`
`22%
`
`309
`146
`163
`
`465
`192
`
`273
`
`27%
`
`339
`165
`
`174
`
`FY19
`FY20
`FY21
`FY22
`Settlement rate is calculated by dividing total settlements by concluded proceedings in
`each fiscal year (i.e., denied institution, settled, dismissed, requested adverse judgment,
`and final written decision), excluding joined cases.
`
`30%
`
`402
`213
`
`189
`
`FY23
`
`9
`
`
`
`Case 1:23-cv-00278-MN Document 54-5 Filed 02/09/24 Page 11 of 17 PageID #: 1065
`
`Outcomes by petition
`(FY23: Oct. 1, 2022 to Sept. 30, 2023)
`
`FWD patentability or unpatentability reported with respect to the claims at issue in the
`FWD. Joined cases are excluded.
`
`10
`
`
`
`Case 1:23-cv-00278-MN Document 54-5 Filed 02/09/24 Page 12 of 17 PageID #: 1066
`
`Outcomes by patent
`(FY23: Oct. 1, 2022 to Sept. 30, 2023)
`
`FWD patentability or unpatentability reported with respect to the claims at issue in the
`FWD. “Mixed Outcome” is shown for patents receiving more than one type of outcome
`from the list of: denied, settled, dismissed, and/or req. adverse judgement only. A patent
`is listed in a FWD category if it ever received a FWD, regardless of other outcomes.
`
`11
`
`
`
`Case 1:23-cv-00278-MN Document 54-5 Filed 02/09/24 Page 13 of 17 PageID #: 1067
`
`Outcomes by claim challenged
`(FY23: Oct. 1, 2022 to Sept. 30, 2023)
`
`12
`
`
`
`Case 1:23-cv-00278-MN Document 54-5 Filed 02/09/24 Page 14 of 17 PageID #: 1068
`
`Claim outcomes
`(FY23: Oct. 1, 2022 to Sept. 30, 2023)
`
`“No DI” and “No FWD” mean
`the claim was challenged but
`not addressed in a DI/FWD, e.g.,
`due to settlement.
`
`30% of challenged claims and
`51% of instituted claims were
`found unpatentable by a
`preponderance of the evidence.
`
`13
`
`
`
`Case 1:23-cv-00278-MN Document 54-5 Filed 02/09/24 Page 15 of 17 PageID #: 1069
`
`All patents: Fiscal Year 2023
`(FY23: Oct. 1, 2022 to Sept. 30, 2023)
`
`Events that end an AIA proceeding include final written decisions (FWD), settlements,
`dismissals, requests for adverse judgment, and denials of institution. A patent is listed in
`an FWD category if it ever received an FWD.
`
`14
`
`
`
`Case 1:23-cv-00278-MN Document 54-5 Filed 02/09/24 Page 16 of 17 PageID #: 1070
`
`All patents: All time
`(All time: Sept. 16, 2012 to Sept. 30, 2023)
`
`15
`
`
`
`Case 1:23-cv-00278-MN Document 54-5 Filed 02/09/24 Page 17 of 17 PageID #: 1071
`Case 1:23-cv-00278-MN Document 54-5 Filed 02/09/24 Page 17 of 17 PagelD #: 1071
`
`
`
`